ROCKWELL MEDICAL, INC. Operating Lease, Expense
ROCKWELL MEDICAL, INC. (RMTI) reported Operating Lease, Expense of $477.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. operating lease, expense for the quarter ending 2026-06-30 was $477.00K, a 2.25% decline year-over-year.
- ROCKWELL MEDICAL, INC. operating lease, expense for the quarter ending 2026-03-31 was $523.00K, a 22.77% increase year-over-year.
- ROCKWELL MEDICAL, INC. operating lease, expense for the quarter ending 2025-12-31 was $477.00K, a 11.19% increase year-over-year.
- ROCKWELL MEDICAL, INC. operating lease, expense for the quarter ending 2025-09-30 was $477.00K, a 14.11% increase year-over-year.
- ROCKWELL MEDICAL, INC. operating lease, expense for fiscal 2025 was $1.87M, a 16.17% increase from fiscal 2024.
- ROCKWELL MEDICAL, INC. operating lease, expense for fiscal 2024 was $1.61M, a 3.83% decline from fiscal 2023.
- ROCKWELL MEDICAL, INC. operating lease, expense for fiscal 2023 was $1.67M, a 2.22% decline from fiscal 2022.
- ROCKWELL MEDICAL, INC. operating lease, expense for fiscal 2022 was $1.71M, a 21.05% decline from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $477.00K 10-Q · filed 2026-08-13 | $1.00M 10-Q · filed 2026-08-13 | $1.48M derived: sum of 3 quarters · filed 2026-08-13 | $1.95M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $523.00K 10-Q · filed 2026-05-07 | $1.00M derived: sum of 2 quarters · filed 2026-05-07 | $1.48M derived: sum of 3 quarters · filed 2026-05-07 | $1.97M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $477.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $954.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.44M derived: sum of 3 quarters · filed 2026-08-13 | $1.87M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $477.00K 10-Q · filed 2025-11-12 | $965.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.39M 10-Q · filed 2025-11-12 | $1.82M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $488.00K 10-Q · filed 2026-08-13 | $914.00K 10-Q · filed 2026-08-13 | $1.34M derived: sum of 3 quarters · filed 2026-08-13 | $1.76M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $426.00K 10-Q · filed 2026-05-07 | $855.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.27M derived: sum of 3 quarters · filed 2026-05-07 | $1.61M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $429.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $847.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.19M derived: sum of 3 quarters · filed 2026-03-26 | $1.61M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $418.00K 10-Q · filed 2025-11-12 | $759.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.18M 10-Q · filed 2025-11-12 | $1.57M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $341.00K 10-Q · filed 2025-08-14 | $761.00K 10-Q · filed 2025-08-14 | $1.15M derived: sum of 3 quarters · filed 2025-08-14 | $1.57M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $420.00K 10-Q · filed 2025-05-12 | $811.00K derived: sum of 2 quarters · filed 2025-05-12 | $1.23M derived: sum of 3 quarters · filed 2025-05-12 | $1.69M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $813.00K derived: sum of 2 quarters · filed 2025-03-20 | $1.27M derived: sum of 3 quarters · filed 2025-03-20 | $1.67M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $422.00K 10-Q · filed 2024-11-12 | $877.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.28M 10-Q · filed 2024-11-12 | $1.70M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $455.00K 10-Q · filed 2024-08-08 | $564.00K 10-Q · filed 2023-08-14 | $859.00K 10-Q · filed 2024-08-08 | $1.08M 10-Q · filed 2023-08-14 | $1.28M derived: sum of 3 quarters · filed 2024-08-08 | $1.69M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $404.00K 10-Q · filed 2024-05-14 | $519.00K 10-Q · filed 2023-05-15 | $825.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.24M derived: sum of 3 quarters · filed 2024-05-14 | $1.76M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $831.00K derived: sum of 2 quarters · filed 2024-03-21 | $1.35M derived: sum of 3 quarters · filed 2024-03-21 | $1.71M 10-K · filed 2024-03-21 | $2.10M 10-K · filed 2023-03-30 | |||
| 2022-09-30 | $410.00K 10-Q · filed 2023-11-14 | $511.00K 10-Q · filed 2022-11-14 | $933.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.29M 10-Q · filed 2023-11-14 | $1.58M 10-Q · filed 2022-11-14 | $2.05M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $523.00K 10-Q · filed 2023-08-14 | $1.07M 10-Q · filed 2023-08-14 | $1.64M derived: sum of 3 quarters · filed 2023-08-14 | $2.19M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $544.00K 10-Q · filed 2023-05-15 | $1.11M derived: sum of 2 quarters · filed 2023-05-15 | $1.67M derived: sum of 3 quarters · filed 2023-05-15 | $2.19M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $571.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.12M derived: sum of 2 quarters · filed 2023-03-30 | $1.64M derived: sum of 3 quarters · filed 2023-03-30 | $2.17M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $551.00K 10-Q · filed 2022-11-14 | $1.07M derived: sum of 2 quarters · filed 2022-11-14 | $1.59M 10-Q · filed 2022-11-14 | $2.06M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $522.00K 10-Q · filed 2022-08-15 | $1.04M 10-Q · filed 2022-08-15 | $1.51M derived: sum of 3 quarters · filed 2022-08-15 | $1.98M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $521.00K 10-Q · filed 2022-05-16 | $987.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.46M derived: sum of 3 quarters · filed 2022-05-16 | $1.99M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $938.00K derived: sum of 2 quarters · filed 2022-04-08 | $1.46M derived: sum of 3 quarters · filed 2022-04-08 | $2.10M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | $472.00K 10-Q · filed 2021-11-15 | $998.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.63M 10-Q · filed 2021-11-15 | $2.17M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $526.00K 10-Q · filed 2021-08-16 | $525.94K 10-Q · filed 2020-08-10 | $1.16M 10-Q · filed 2021-08-16 | $1.16M 10-Q · filed 2020-08-10 | $1.70M derived: sum of 3 quarters · filed 2021-08-16 | $2.32M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $632.00K 10-Q · filed 2021-05-17 | $632.11K 10-Q · filed 2020-05-11 | $1.18M derived: sum of 2 quarters · filed 2021-05-17 | $1.80M derived: sum of 3 quarters · filed 2021-05-17 | $2.43M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $544.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.17M derived: sum of 2 quarters · filed 2021-03-31 | $1.80M derived: sum of 3 quarters · filed 2021-03-31 | $2.39M 10-K · filed 2021-03-31 | $2.39M 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $622.00K 10-Q · filed 2020-11-09 | $622.12K 10-Q · filed 2019-11-12 | $1.26M derived: sum of 2 quarters · filed 2020-11-09 | $1.85M 10-Q · filed 2020-11-09 | $1.85M 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $633.16K 10-Q · filed 2020-08-10 | $1.26M 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | $624.81K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |